← Back to Search

Stent

WallFlex Biliary Fully Covered Stent for Anastomotic Biliary Stricture

N/A
Waitlist Available
Led By Divyesh Sejpal, M.D.
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post stent removal
Awards & highlights

Summary

The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.

Eligible Conditions
  • Anastomotic Biliary Stricture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post stent removal
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post stent removal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stricture Resolution at the Time of Stent Removal.
Secondary outcome measures
Effectiveness of Stent at 6 Months
Re-intervention Occurrence
Safety
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: WallFlex Biliary Fully Covered StentExperimental Treatment1 Intervention
All eligible patients entered into the study will be treated with a WallFlex Biliary Fully Covered Stent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
WallFlex Biliary Fully Covered Stent
2009
N/A
~10

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
737 Previous Clinical Trials
854,226 Total Patients Enrolled
Divyesh Sejpal, M.D.Principal InvestigatorIcahn School of Medicine at Mount Sinai
~1 spots leftby Sep 2025